Hyderabad Telangana, India

Madhusudhan Malladi


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Madhusudhan Malladi

Introduction

Madhusudhan Malladi is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of stable formulations for cancer treatment. With a total of 2 patents, his work is recognized for its potential impact on patient care.

Latest Patents

Madhusudhan Malladi's latest patents focus on stable pharmaceutical formulations of pemetrexed. The first patent describes a long-term storage stable multi-dose ready-to-use or ready-to-dilute pharmaceutical liquid formulation comprising pemetrexed or a pharmaceutically acceptable salt thereof, along with an antioxidant, a preservative, a buffering agent, and a pharmaceutically acceptable fluid. This invention also includes a process for preparing the formulation, a kit, and a method for treating patients with lung cancer by administering the pharmaceutical formulation to those in need.

Career Highlights

Madhusudhan Malladi is currently associated with Cipla Limited, a leading pharmaceutical company. His work at Cipla has allowed him to focus on innovative solutions that enhance the efficacy and stability of pharmaceutical products.

Collaborations

Madhusudhan has collaborated with notable colleagues such as Sarabjit Singh and Alagumurugan Alagarswamy. Their combined expertise contributes to the advancement of pharmaceutical innovations.

Conclusion

Madhusudhan Malladi's contributions to pharmaceutical formulations demonstrate his commitment to improving cancer treatment options. His innovative patents and collaborations highlight the importance of research and development in the healthcare sector.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…